These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 6689351)

  • 1. Gout and uric acid nephropathy: some new aspects in diagnosis and treatment.
    Löffler W; Simmonds HA; Gröbner W
    Klin Wochenschr; 1983 Dec; 61(24):1233-9. PubMed ID: 6689351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of urate-lowering therapies on renal handling of uric acid.
    Ma L; Wei L; Chen H; Zhang Z; Yu Q; Ji Z; Jiang L
    Clin Rheumatol; 2016 Jan; 35(1):133-41. PubMed ID: 25373449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia and gout: an update.
    Khachadurian AK
    Am Fam Physician; 1981 Dec; 24(6):143-8. PubMed ID: 6895439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi.
    Emmerson BT
    Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609
    [No Abstract]   [Full Text] [Related]  

  • 5. Lesinurad: A Review in Hyperuricaemia of Gout.
    Deeks ED
    Drugs Aging; 2017 May; 34(5):401-410. PubMed ID: 28425024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F; Saporta L; de Géry A; Jabre E
    Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
    [No Abstract]   [Full Text] [Related]  

  • 7. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W; Zöllner N
    Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The treatment of gout and disorders of uric acid metabolism with allopurinol.
    Ogryzlo MA; Urowitz MB; Weber HM; Houpt JB
    Can Med Assoc J; 1966 Nov; 95(22):1120-7. PubMed ID: 5923471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of anti-inflammatory therapies, xanthine oxidase inhibitors and other urate-lowering therapies on cardiovascular diseases in gout.
    Richette P; Frazier A; Bardin T
    Curr Opin Rheumatol; 2015 Mar; 27(2):170-4. PubMed ID: 25594854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug treatment of gout.
    Kelley WN; Wyngaarden JB
    Semin Drug Treat; 1971 Sep; 1(2):119-47. PubMed ID: 4949305
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on emerging urate-lowering therapies.
    Chohan S; Becker MA
    Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic approach to the maintenance of urate homeostasis.
    Kelley WN
    Nephron; 1975; 14(1):99-115. PubMed ID: 1091870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term management of gout and hyperuricaemia.
    Scott JT
    Br Med J; 1980 Nov; 281(6249):1164-6. PubMed ID: 6775757
    [No Abstract]   [Full Text] [Related]  

  • 14. [Choice between uricosurics and inhibitors of uric acid synthesis in the treatment of gout].
    Kono H; Yonezawa H; Naito H
    Nihon Rinsho; 1975 Feb; 33(2):356-60. PubMed ID: 1170378
    [No Abstract]   [Full Text] [Related]  

  • 15. Gout: on the brink of novel therapeutic options for an ancient disease.
    Bieber JD; Terkeltaub RA
    Arthritis Rheum; 2004 Aug; 50(8):2400-14. PubMed ID: 15334451
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of gout.
    Goldfinger SE
    N Engl J Med; 1971 Dec; 285(23):1303-6. PubMed ID: 4941493
    [No Abstract]   [Full Text] [Related]  

  • 17. Change gout: how to deal with this "silently-developing killer" in everyday clinical practice.
    Scirè CA; Rossi C; Punzi L; Genderini A; Borghi C; Grassi W
    Curr Med Res Opin; 2018 Aug; 34(8):1411-1417. PubMed ID: 29553292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gout, uric acid and purine metabolism in paediatric nephrology.
    Cameron JS; Moro F; Simmonds HA
    Pediatr Nephrol; 1993 Feb; 7(1):105-18. PubMed ID: 8439471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
    Zychowicz ME; Pope RS; Graser E
    J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT.
    KLINENBERG JR; GOLDFINGER SE; SEEGMILLER JE
    Ann Intern Med; 1965 Apr; 62():639-47. PubMed ID: 14274828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.